78186-34-2
78186-34-2
Chemical Structure
Bisantrene
Synonym(s): CL216942
- CAS No.: 78186-34-2
- Formula:C22H22N8
- Molecular Weight:398.46
IUPAC Name: 9,10-bis((E)-(2-(4,5-dihydro-1H-imidazol-2-yl)hydrazono)methyl)anthracene
InChIKey: NJSMWLQOCQIOPE-OCHFTUDZSA-N
SMILES: C12=CC=CC=C1C(/C=N/NC3=NCCN3)=C4C(C=CC=C4)=C2/C=N/NC5=NCCN5
Biological Activity: Bisantrene is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene targets eukaryotic type II topoisomerases. Bisantrene is a substrate of MDR1[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bisantrene | 98.06% | Bisantrene is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene targets eukaryotic type II topoisomerases. Bisantrene is a substrate of MDR1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisantrene (Standard) | ≥98% | Bisantrene (Standard) is the analytical standard of Bisantrene. This product is intended for research and analytical applications. Bisantrene is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene targets eukaryotic type II topoisomerases. Bisantrene is a substrate of MDR1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.98
HY-100875ARBisantrene dihydrochloride (Standard) -
Similarity Score 0.54
HY-W112914(2E,2'E)-3,3'-(Anthracene-9,10-diyl)diacrylic acid -
Similarity Score 0.54
HY-W0754769,10-Bis(2-(pyridin-4-yl)vinyl)anthracene -
Similarity Score 0.54
HY-W0754779,10-Bis((E)-2-(pyridin-4-yl)vinyl)anthracene -
Similarity Score 0.51
HY-D0324Pigment Yellow 101 -
Similarity Score 0.51
HY-122221KUM 32 -
Similarity Score 0.51
HY-163158DHODH-IN-24 -
Similarity Score 0.50
HY-W0044609,10-Dimethylanthracene -
Similarity Score 0.50
HY-108638RNSC 146109 hydrochloride (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. Sissi C, et al. DNA-binding preferences of Bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning. Mol Pharmacol. 1998 Dec;54(6):1036-45. [Content Brief]
- [2]. Yap HY, et al. Bisantrene, an active new drug in the treatment of metastatic breast cancer. Cancer Res. 1983 Mar;43(3):1402-4. [Content Brief]
- [3]. Wang BS, et al. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene). Cancer Res. 1984 Jun;44(6):2363-7. [Content Brief]
- [4]. Aksentijevich I, et al. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity. Clin Cancer Res. 1996 Jun;2(6):973-80. [Content Brief]
